Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers. Urol Oncol. 2016 12; 34(12):556-565.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antigen-Presenting Cells
Antigens, Neoplasm
Antineoplastic Agents, Immunological
B7-H1 Antigen
Carcinoma, Transitional Cell
Clinical Trials as Topic
Costimulatory and Inhibitory T-Cell Receptors
Humans
Immunotherapy
Lymphocyte Activation
Lymphocytes, Tumor-Infiltrating
Molecular Targeted Therapy
Mutation
Neoplasm Proteins
Programmed Cell Death 1 Receptor
Receptors, Antigen, T-Cell
Therapies, Investigational
T-Lymphocytes, Cytotoxic
Tumor Escape
Tumor Microenvironment
Urinary Bladder Neoplasms
authors with profiles
Randy Sweis